'Many papers in biomedical journals are drafted not by the named authors, but by professional medical writers working under the direction of those authors, usually funded by pharmaceutical companies. Although this practice can improve both the quality and speed of publications, it has attracted controversy as a result of concerns about the inappropriate influence of pharmaceutical companies.'

Jacobs, A.; Wager, E. (2005). "European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications". Curr Med Res Opin. 21 (2): 317–321. doi:10.1185/030079905x25578.

Similar questions and discussions